A team of scientists researching solutions for the effects of Covid-19 , Parkinson’s, Alzheimer’s and other debilitating conditions have opened a new office at Sandwich's Discovery Park .

Biology company Transpharmation, founded in 2010, is moving into its largest laboratory yet and says it will be creating a number of new jobs in the process.

Founded by Dr Neil Upton and Dr Mark Duxon, the team has contributed significantly to UK and world-wide understanding of a range of health conditions.

Chief executive officer Dr Duxon, said: “We are looking forward to opening in Discovery Park. We have always thought it was important to invest in the future for new scientists too – we fund a number of PhD students in the UK and Ireland, for example – and chose Discovery Park in part because it places a similar emphasis on young scientists. We are looking forward to immersing Transpharmation in the STEM and school education activities on the park.”

Transpharmation is a contract research organisation – partnering with other laboratories to provide research experiments and data to show how medical drugs or components interact with the body.

It has more than 100 clients internationally, already working from its established bases The London Bioscience Innovation Centre, Royal Veterinary College and Trinity College Institute of Neuroscience, Dublin – and now at Discovery Park which will become its primary and largest site.

The new laboratory and its proximity to other specialist research organisations will provide additional research capability for Transpharmation, allowing the team to scale up and accelerate its drug discovery support for life-changing medicines.

Dr Duxon added: “Discovery Park has a long scientific heritage of drug discovery for human health - we are pleased that we are able to continue and add to this reputation and cement British leadership in this essential field.”

Job details will be announced in due course.

Head to our business page for all of the latest news about businesses in Kent